Copyright
©2013 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Feb 16, 2013; 5(2): 67-73
Published online Feb 16, 2013. doi: 10.4253/wjge.v5.i2.67
Published online Feb 16, 2013. doi: 10.4253/wjge.v5.i2.67
Table 1 Patients’ characteristics and indications for small bowel capsule endoscopy (%)
| Group AOvernight fast(n = 20) | Group BPEG(n = 18) | Group CPEG + simethicone(n = 19) | P value | |
| Age (yr) | 51.8 ± 21.6 | 50.4 ± 17.5 | 58.4 ± 18.8 | 0.437 |
| Sex N female (%) | 11 (55) | 11 (61.1) | 9 (47.4) | 0.702 |
| Indication | 0.403 | |||
| Occult OGIB | 9 | 7 | 6 | |
| Overt OGIB | 5 | 0 | 5 | |
| Suspected CD | 3 | 6 | 3 | |
| CD | 3 | 2 | 3 | |
| Chronic diarrhea | 0 | 1 | 1 | |
| Suspected SB neoplasia | 0 | 2 | 1 |
- Citation: Rosa BJF, Barbosa M, Magalhães J, Rebelo A, Moreira MJ, Cotter J. Oral purgative and simethicone before small bowel capsule endoscopy. World J Gastrointest Endosc 2013; 5(2): 67-73
- URL: https://www.wjgnet.com/1948-5190/full/v5/i2/67.htm
- DOI: https://dx.doi.org/10.4253/wjge.v5.i2.67